ALX Oncology Holdings Inc.
ALXO
$2.11
-$0.07-3.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.14% | 13.57% | 35.87% | 39.78% | -15.34% |
| Total Depreciation and Amortization | -13.18% | -1.40% | 3.38% | 7.18% | 6.28% |
| Total Amortization of Deferred Charges | 4.55% | 4.69% | 7.81% | 4.76% | 6.45% |
| Total Other Non-Cash Items | -13.92% | -12.95% | 7.74% | 17.16% | 29.51% |
| Change in Net Operating Assets | -151.08% | 107.54% | -2,746.53% | -109.36% | 328.81% |
| Cash from Operations | 11.89% | 34.97% | 19.23% | 18.56% | 16.22% |
| Capital Expenditure | 47.78% | 59.46% | 59.46% | -111.44% | 94.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,143.03% | 4.07% | 301.25% | 124.48% | -87.46% |
| Cash from Investing | 2,360.42% | 4.43% | 299.11% | 100.49% | -85.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.72% | -75.43% | -20.63% | -222.52% | -103.74% |
| Issuance of Common Stock | -99.95% | -88.59% | -99.93% | -- | 5,982.22% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 108.16% | -- | -- |
| Cash from Financing | -100.82% | -97.89% | -99.45% | 326.13% | 7,816.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -187.88% | 136.43% | -48.09% | 103.08% | 105.94% |